Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]:
SEC Accession No. 0001104659-24-004960
Filing Date
2024-01-19
Accepted
2024-01-19 06:04:18
Documents
7
Effectiveness Date
2024-01-19

Document Format Files

Seq Description Document Type Size
1 S-3MEF tm243583d1_s3mef.htm S-3MEF 37668
2 EXHIBIT 5.1 tm243583d1_ex5-1.htm EX-5.1 31754
3 EXHIBIT 23.1 tm243583d1_ex23-1.htm EX-23.1 3214
4 EX-FILING FEES tm243583d1_ex-filingfees.htm EX-FILING FEES 32173
5 GRAPHIC tm243583d1_ex23-1img001.jpg GRAPHIC 7047
6 GRAPHIC tm243583d1_ex5-1img01.jpg GRAPHIC 3887
7 GRAPHIC tm243583d1_ex5-1img02.jpg GRAPHIC 2050
  Complete submission text file 0001104659-24-004960.txt   124224
Mailing Address 1715 38TH ST BOULDER CO 80301
Business Address 1715 38TH ST BOULDER CO 80301 720-262-7002
Edgewise Therapeutics, Inc. (Filer) CIK: 0001710072 (see all company filings)

EIN.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3MEF | Act: 33 | File No.: 333-276595 | Film No.: 24543645
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)